Dataset Information


MicroRNA-199b Deregulation Shows a Strong SET-Independent Prognostic Value in Early-Stage Colorectal Cancer.

ABSTRACT: The endogenous PP2A inhibitor SET Nuclear Proto-Oncogene (SET) has been reported to play oncogenic roles and determines poor outcomes in colorectal cancer (CRC). Our group previously showed that miR-199b is deregulated in metastatic CRC, and reduced the cell viability and enhanced the sensitivity of CRC cells to standard induction chemotherapy drugs, mainly through direct negative SET regulation. Clinically, miR-199b downregulation was identified as the molecular mechanism responsible for SET overexpression in around half of metastatic CRC patients. However, the potential clinical value of miR-199b in early-stage CRC remains totally unknown. Thus, here we explored the expression levels of this microRNA in a cohort of 171 early-stage CRC patients using real-time polymerase chain reactions. MiR-199b downregulation was found in 21.6% of cases (37 out of 171) and was significantly associated with those patients with a worse Eastern Cooperative Oncology Group (ECOG) status (p = 0.045). Moreover, miR-199b downregulation predicted shorter overall (p < 0.001) and progression-free survival (p = 0.015). As expected, we next immunohistochemically analyzed SET, observing that it was significantly associated with miR-199b in our cohort. However, multivariate analyses showed that miR-199b was an independent biomarker of poor outcomes in early-stage CRC with a predictive value stronger than SET. In conclusion, our results highlight the potential clinical usefulness of miR-199b and suggest that it could represent a novel molecular target in this disease.

SUBMITTER: Cristobal I 

PROVIDER: S-EPMC7465379 | BioStudies | 2020-01-01

REPOSITORIES: biostudies

Similar Datasets

| S-EPMC5522310 | BioStudies
2020-01-01 | S-EPMC7352382 | BioStudies
2019-01-01 | S-EPMC6463201 | BioStudies
| S-EPMC5085212 | BioStudies
1000-01-01 | S-EPMC3337299 | BioStudies
1000-01-01 | S-EPMC5520514 | BioStudies
2009-01-01 | S-EPMC2656623 | BioStudies
2015-01-01 | S-EPMC4740997 | BioStudies
1000-01-01 | S-EPMC5123084 | BioStudies
| S-EPMC6096423 | BioStudies